These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20019880)

  • 41. Vascular endothelial growth factor gene variation and the response to photodynamic therapy in age-related macular degeneration.
    Immonen I; Seitsonen S; Tommila P; Kangas-Kontio T; Kakko S; Savolainen ER; Savolainen MJ; Liinamaa MJ
    Ophthalmology; 2010 Jan; 117(1):103-8. PubMed ID: 19896188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor single nucleotide polymorphisms and haplotypes in pre-eclampsia: A case-control study.
    Ben Ali Gannoun M; Al-Madhi SA; Zitouni H; Raguema N; Meddeb S; Hachena Ben Ali F; Mahjoub T; Almawi WY
    Cytokine; 2017 Sep; 97():175-180. PubMed ID: 28651127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The presence of CFH, HTRA1, ARMS2, VEGF-A and VEGF-R and the appearance of age-related macular degeneration sub-types.
    Cruz-González F; Cabrillo Estévez L; Cañete Campos C; Sánchez-Jara Sánchez A; Juan Marcos L; González-Sarmiento R
    Arch Soc Esp Oftalmol; 2016 Apr; 91(4):177-83. PubMed ID: 26850328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of Polymorphisms in CX3CR1, PLEKHA1 and VEGF genes as risk factors for age-related macular degeneration in Indian patients.
    Gupta D; Gupta V; Singh V; Chawla S; Parveen F; Agrawal S; Phadke SR
    Arch Med Res; 2014 Aug; 45(6):489-94. PubMed ID: 25050486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exudative Age-Related Macular Degeneration: Association between Treatment Efficacy and Single-Nucleotide Variants in
    Vilkeviciute A; Cebatoriene D; Kriauciuniene L; Zaliuniene D; Liutkeviciene R
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 38999967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gender specific association of a complement component 3 polymorphism with polypoidal choroidal vasculopathy.
    Liu K; Lai TY; Chiang SW; Chan VC; Young AL; Tam PO; Pang CP; Chen LJ
    Sci Rep; 2014 Nov; 4():7018. PubMed ID: 25388911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Risk Alleles in CFH, C3, and VEGFA on the Response to Intravitreal Bevacizumab in Tunisian Patients with Neovascular Age-related Macular Degeneration.
    Habibi I; Kort F; Sfar I; Chebil A; Bouraoui R; Ben Abdallah T; Gorgi Y; El Matri L
    Klin Monbl Augenheilkd; 2016 Apr; 233(4):465-70. PubMed ID: 27116510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Roles of three common VEGF polymorphisms in the risk of age-related macular degeneration.
    Liu Y; Hou S; Lang W; Dai D; Wang Z; Ji X; Li K; Zhang X; Zou Y; Wang J
    Genet Test Mol Biomarkers; 2014 Apr; 18(4):245-52. PubMed ID: 24689893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic predictive biomarkers of anti-VEGF treatment response in patients with neovascular age-related macular degeneration.
    Fauser S; Lambrou GN
    Surv Ophthalmol; 2015; 60(2):138-52. PubMed ID: 25596882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-vascular endothelial growth factor therapy for ocular neovascular disease.
    Andreoli CM; Miller JW
    Curr Opin Ophthalmol; 2007 Nov; 18(6):502-8. PubMed ID: 18163003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration.
    Cobos E; Recalde S; Anter J; Hernandez-Sanchez M; Barreales C; Olavarrieta L; Valverde A; Suarez-Figueroa M; Cruz F; Abraldes M; Pérez-Pérez J; Fernández-Robredo P; Arias L; García-Layana A
    Acta Ophthalmol; 2018 Mar; 96(2):e201-e212. PubMed ID: 28926193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss.
    Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML
    J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic influences on the outcome of anti-vascular endothelial growth factor treatment in neovascular age-related macular degeneration.
    Abedi F; Wickremasinghe S; Richardson AJ; Islam AF; Guymer RH; Baird PN
    Ophthalmology; 2013 Aug; 120(8):1641-8. PubMed ID: 23582991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population.
    Janik-Papis K; Zaras M; Krzyzanowska A; Wozniak K; Blasiak J; Szaflik J; Szaflik JP
    Exp Mol Pathol; 2009 Dec; 87(3):234-8. PubMed ID: 19761764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration.
    Ambreen F; Ismail M; Qureshi IZ
    Mol Vis; 2015; 21():985-99. PubMed ID: 26330749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Profile of conbercept in the treatment of neovascular age-related macular degeneration.
    Lu X; Sun X
    Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of vascular endothelial growth factor polymorphisms in the treatment success in patients with wet age-related macular degeneration.
    Boltz A; Ruiß M; Jonas JB; Tao Y; Rensch F; Weger M; Garhöfer G; Frantal S; El-Shabrawi Y; Schmetterer L
    Ophthalmology; 2012 Aug; 119(8):1615-20. PubMed ID: 22521084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of VEGFA variants with altered VEGF secretion and type 2 diabetes: A case-control study.
    Sellami N; Lamine LB; Turki A; Sarray S; Jailani M; Al-Ansari AK; Ghorbel M; Mahjoub T; Almawi WY
    Cytokine; 2018 Jun; 106():29-34. PubMed ID: 29533820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Investigation of genetic base in the treatment of age-related macular degeneration.
    Gourgouli K; Gourgouli I; Tsaousis G; Spai S; Niskopoulou M; Efthimiopoulos S; Lamnissou K
    Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.
    Park KH; Ryu E; Tosakulwong N; Wu Y; Edwards AO
    Mol Vis; 2009; 15():200-7. PubMed ID: 19169411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.